720 related articles for article (PubMed ID: 17426078)
1. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
Paredes AH; Lewis JH
Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
[TBL] [Abstract][Full Text] [Related]
2. Oral terbinafine-induced bullous pemphigoid.
Aksakal BA; Ozsoy E; Arnavut O; Ali Gürer M
Ann Pharmacother; 2003 Nov; 37(11):1625-7. PubMed ID: 14565807
[TBL] [Abstract][Full Text] [Related]
3. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
4. Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
Franck AJ; Sliter LR
Ann Pharmacother; 2009 Sep; 43(9):1539-43. PubMed ID: 19638471
[TBL] [Abstract][Full Text] [Related]
5. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine.
Lovell MO; Speeg KV; Havranek RD; Sharkey FE
Hum Pathol; 2003 Feb; 34(2):187-9. PubMed ID: 12612888
[TBL] [Abstract][Full Text] [Related]
6. [Polyclonal activation due to Epstein-Barr virus superinfection in a case with chronic hepatitis B].
Bakir Ozbey S; Mistik R; Gürcüoğlu E; Oral B; Göral G
Mikrobiyol Bul; 2007 Oct; 41(4):607-12. PubMed ID: 18173082
[TBL] [Abstract][Full Text] [Related]
7. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
[TBL] [Abstract][Full Text] [Related]
8. Terbinafine-associated hepatic injury.
van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
[TBL] [Abstract][Full Text] [Related]
9. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune hepatitis caused by acute hepatitis due to hepatitis A virus].
Muñoz Bertrán E; Rosa Salazar V; Hostalet Robles F; Correa Estañ JA; Belda Abad G; Muñoz Ramírez E
Gastroenterol Hepatol; 2002 Oct; 25(8):501-4. PubMed ID: 12361532
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
Tavakkol A; Fellman S; Kianifard F
Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
[TBL] [Abstract][Full Text] [Related]
12. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
[TBL] [Abstract][Full Text] [Related]
13. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
[TBL] [Abstract][Full Text] [Related]
14. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
[TBL] [Abstract][Full Text] [Related]
15. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
[TBL] [Abstract][Full Text] [Related]
16. Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B.
Hasanjani Roushan MR; Hajiahmadi M; Shafaie S
Int J Clin Pract; 2005 Jul; 59(7):791-4. PubMed ID: 15963206
[TBL] [Abstract][Full Text] [Related]
17. Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.
Wong VW; Chan HL
J Gastroenterol Hepatol; 2009 Jul; 24(7):1179-86. PubMed ID: 19682192
[TBL] [Abstract][Full Text] [Related]
18. Terbinafine-induced hepatic dysfunction.
Chambers WM; Millar A; Jain S; Burroughs AK
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1115-8. PubMed ID: 11564966
[TBL] [Abstract][Full Text] [Related]
19. Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis.
Tuccori M; Bresci F; Guidi B; Blandizzi C; Del Tacca M; Di Paolo M
Ann Pharmacother; 2008 Jul; 42(7):1112-7. PubMed ID: 18523232
[TBL] [Abstract][Full Text] [Related]
20. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
Gupta AK; Lynch LE; Kogan N; Cooper EA
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
